Other languages GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:04 2024-05-31 am EDT			5-day change	1st Jan Change
1,766 ^GBX	+2.11%		-0.45%	+21.81%

09:35am	GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	RE
May. 31	US FDA approves Moderna's RSV vaccine, its second marketed product	RE

GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	03:35am
US FDA approves Moderna's RSV vaccine, its second marketed product	May. 31
Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	May. 30
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	May. 30
Jefferies and UBS cut Anglo American	May. 30
Dr Martens cuts payout as profit plummets	May. 30
GSK : Upgraded to Neutral by Goldman Sachs	May. 30
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	May. 30
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	May. 29
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	May. 29
CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate	May. 28
US, European nations consider vaccinating workers exposed to bird flu	May. 27
British Stocks Extend Losing Streak Amid Retail Sales Slump	May. 24
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases - Form 6-K	May. 24
Rate outlook weighs on equities	May. 24
GSK : obtient gain de cause dans une affaire liée au Zantac	May. 24
New data at ASCO showcases the transformational potential of GSK's oncology portfolio \| GSK	May. 24
GSK : va présenter ses avancées en oncologie lors de l'ASCO	May. 24
Statement: Zantac (ranitidine) litigation - Valadez and Williams cases \| GSK	May. 24
FTSE 100 falls; retail sales plunge in April	May. 24

No results for this search

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT

GSK PLC : Encouraging start to 2024; guidance raised